Industry committee  Yes.

Industry committee  Perhaps I can jump in here to indicate that in fact Bill C-25 actually goes an explicit step further. Currently, under securities commissions' laws in eight of the securities commissions in the country, corporations on an annual basis already need to file the gender makeup of their board and the gender makeup of their senior management.

Industry committee  What the bill does is facilitate a conversation between shareholders and the corporation. The acceptability would be up to the shareholders. On an annual basis, they'd have the opportunity to make representations to their firm and to indicate whether this diversity policy was sufficient for their purposes.

International Trade committee  A wide range of estimates has been provided on the potential costs of pharmaceutical changes under the intellectual property provisions of the act. There has been a number of those sets of analyses. It's extremely difficult work. In fact, we don't believe the estimates we would be able to provide would meaningfully advance the issues, because we have no foresight as to the nature of the drugs that will potentially be on the market, post the coming into force, for those that would actually benefit from a certificate of supplementary protection, for instance.

International Trade committee  It's not a study. It's data. I can't speak to what the PBO has in their possession. I can say, from our perspective as the department responsible for the intellectual property statutes, that in our assessment, based on what we see as the changes to the intellectual property statutes, it would be very difficult to predict what the potential impacts would be, given the forward nature of the changes being proposed.

International Trade committee  Our view, in consulting and meeting with stakeholders, is that these powers are required for the regulation-making power that we believe is necessary for effective appeal rights, and in consequence, for the ending of dual litigation. It's fair to say that, as you indicated, this is a zone of particular litigation, and ensuring that we have effective regulation-making authority is a critical aspect of ensuring that we have the capacity to implement as we've set out.

International Trade committee  The intent is to ensure that we've actually given ourselves the authority so that parties cannot potentially use this provision to suggest that we don't have the regulation-making authority to move forward.

International Trade committee  We've engaged with stakeholders of every nature in the pharmaceutical industry, including the Canadian Generic Pharmaceutical Association, in trying to ensure that we get the balance right and can implement effectively.

International Trade committee  In consultation with stakeholders, with respect to section 62, there has been previous action to repeal this clause. We have come to the conclusion, following our consideration, that a portion of it is useful to us and is necessary. The coordinating amendment is in line with drafting convention and gets at the same aim.

International Trade committee  Mr. Chair, in the balance of the agreement, on the pharmaceutical provisions and the intellectual property provisions, there were elements that were specifically in the CETA text, and then there were portions that were fundamental to the balance we struck for the Canadian implementation.

International Trade committee  I'll actually turn to my other colleague on that.

Canadian Heritage committee  I'll start at the policy level on the diversity of voices piece. With respect to the specific aspect of diversity of voices, as my colleagues from the bureau have indicated, it's not in their act to necessarily look at transactions within that lens. There are aspects of diversity of voices that are captured by lenses that are afforded to the bureau, particularly when it looks at the degree of competition, the number of competitors in a space, and the degree to which one competitor may negatively impact the overall state of the sector.

Canadian Heritage committee  At Innovation, Science and Economic Development Canada, one of the tenets of the inclusive innovation agenda was the adaptation to the digital world, recognizing that a huge piece of the economy of the future, the modern economy, will be in this new world of Internet of things and streaming platforms and access to these sorts of digital industries.

Canadian Heritage committee  I'll just add that for new entities, organizations that wouldn't be as a function of a merger or an acquisition, one of the drives towards innovation within Innovation, Science and Economic Development is to facilitate ease of doing business. That is one of the reasons why incorporation in Canada remains an easy process.

Canadian Heritage committee  We do have folks who look at retail—